secwatch.observer — SEC 8-K summary
======================================

Issuer:     PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK:        0001401667
Form:       8-K
Filed at:   2022-08-02T23:59:59+00:00
Accession:  0001437749-22-018452
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Puma Biotechnology appoints Alessandra Cesano to Board of Directors
-------------------------------------------------------------------

- Dr. Cesano appointed effective July 29, 2022, also to R&D Committee.
- She has served as CMO of ESSA Pharmaceuticals since 2019, previously CMO at NanoString.
- Received option to purchase 100,000 shares at $2.93/share, vesting over 3 years.
- Term expires at 2023 Annual Meeting; standard director compensation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401667/000143774922018452/0001437749-22-018452-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401667/000143774922018452/pbyi20220727_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-018452

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer